Gilead Sciences, Inc. (GILD)


Stay up to date

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead's medicines today reach millions of people in low- and middle-income countries around the world. In the United States, Gilead has committed more than $100 million over 10 years through the COMPASS Initiative to community organizations that are working to combat HIV in the Southern United States. In 2020, Gilead launched the Racial Equity Community Impact Fund to support organizations tackling racial inequities affecting Black communities across the United States.

Financial Statements

Key Info

  • Industry: Biological Product (except Diagnostic) Manufacturing
  • Sector: Manufacturing
  • CEO Name: Daniel O'Day

Key Statistics

  • Stock Price: $59.45
  • Dividend Yield: 4.7%
  • Market Capitalization: $74,806,881,954
  • Shares Outstanding: 1,253,886,724
  • Number of Employees: 13,600
  • Trailing 12-Month EPS: $4.93
  • Trailing 12-Month DPS: $2.81
  • Payout Ratio: 56.99999999999999%

Important Dates

  • Next Earnings Date: 2022-04-28
  • Next Ex-Dividend Date: 2022-03-14

Price Trends

  • Current Stock Price: $59.45
  • 52-week high: $73.19
  • 52-week low: $56.6
  • 200-day moving average: $65.85
  • 50-day moving average: $59.64


  • 1-Month Price Return: -1.1%
  • 3-Month Price Return: -17.6%
  • 6-Month Price Return: -14.0%
  • 1-Year Price Return: -4.9%
  • 2-Year Price Return: -14.5%
  • 5-Year Price Return: 6.2%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast